Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility

scientific article

Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1515/ADDGE-2015-0001
P932PMC publication ID4720149
P698PubMed publication ID26807291
P5875ResearchGate publication ID282401533

P50authorKenneth BlumQ6389872
Rajendra BadgaiyanQ19938391
James L FratantonioQ114407804
Mary HauserQ114407813
P2860cites workThe genetic basis of addictive disordersQ24607129
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS)Q28652508
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trialsQ31138857
The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addictionQ33579769
Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch.Q33609822
Genetic risk prediction and neurobiological understanding of alcoholismQ33672725
Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.Q34304684
Allelic association of human dopamine D2 receptor gene in alcoholismQ34998499
Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese populationQ35016329
Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)?Q35053937
Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependenceQ35085081
Transcriptome organization for chronic alcohol abuse in human brain.Q35674997
Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation rewardQ36234280
Pharmacogenetics of opioid receptors and addictionQ36339767
Using genetic information from candidate gene and genome-wide association studies in risk prediction for alcohol dependenceQ36876237
Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidenceQ36928468
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addictsQ37164595
Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative moodQ37280300
Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoringQ37876422
Alterations in brain connectivity in three sub-regions of the anterior cingulate cortex in heroin-dependent individuals: Evidence from resting state fMRI.Q39090343
The D2 dopamine receptor gene as a predictor of compulsive disease: Bayes' theoremQ40468073
The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP.Q40575056
Candidate genes in alcoholism.Q40976810
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trialQ44626401
Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderatorsQ45285800
Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research of complex behavioral disordersQ46287440
Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients.Q52275787
The D2 dopamine receptor gene as a determinant of reward deficiency syndrome.Q55331780
Tapentadol Abuse Potential: A Postmarketing Evaluation Using a Sample of Individuals Evaluated for Substance Abuse TreatmentQ60682780
Association between the D2 dopamine receptor gene and alcoholism. A continuing controversyQ67961284
What can the DRD2/alcoholism story teach us about association studies in psychiatric genetics?Q71552324
P275copyright licenseCreative Commons Attribution-NonCommercial-NoDerivs 3.0 UnportedQ19125045
P6216copyright statuscopyrightedQ50423863
P433issue1
P304page(s)1-5
P577publication date2015-07-01
P1433published inAddiction geneticsQ27725310
P1476titleMolecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility
P478volume2

Search more.